News

The International Menopause society has issued a detailed press release in response to The Lancet's recent publication of a report suggesting an increase in the risks of breast cancer for women taking HRT.

The UK's first specialist training course in yoga and wellbeing for menopause is being launched at Newson Health in November. This course will certify qualified yoga teachers to lead workshops and classes in Menopause Yoga. Read on for more details...

A Global Position Statement has been issued to inform healthcare professionals of the known benefits and risks of testosterone therapy for women. Read on for more information...

In this article written by Dr Louise Newson, and recently published in the Telegraph, she explains why she's sticking with HRT, despite an increase in "scary-sounding headlines." Read on for the full story...

Leading breast cancer specialist, Professor Michael Baum, called the Lancet's recent reporting on the increased risk of breast cancer from HRT "irresponsible". Read his response to them here.

Katie Taylor, founder of The Latte Lounge and Professor Michael Baum, leading breast cancer specialist, put viewers straight about the recent reports on increased risk of breast cancer from HRT. Watch the video.

In this article, leading oncoplastic breast surgeon, Professor Kefah Mokbel, explains why the latest scaremongering reports will not change his positive views of HRT. 

Watch Dr Louise Newson on BBC News  and hear her explain why women should not panic over today's report on HRT breast cancer risks.

An article published in The Lancet medical journal today has been sensationalised in the media suggesting that the breast cancer risk from using HRT is twice what was thought. Here, Dr Louise Newson seeks to reassure women and explain why there is no cause for panic.

GP and renowned menopause expert, Dr Louise Newson, has launched a Haynes manual on Menopause to dispel myths and provide women, their partners and families with vital information about symptoms, lifestyle changes and treatments available.